Pravin Dugel - 02 Jan 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role: President, Director
Signature: /s/ Todd D.C. Anderman, as Attorney-in-Fact for Pravin U. Dugel
Issuer symbol: N/A
Transactions as of: 02 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 17:35:15 UTC
Previous filing: 22 Dec 2022
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$0	+12,500	+9.2%	$0.000000	148,723	02 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Restricted Stock Units	Options Exercise	$0	-12,500	-25%	$0.000000	37,500	02 Jan 2023	Common Stock	12,500		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
F2	On December 16, 2021, the Reporting Person was granted 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.